Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion

Annals of the Rheumatic Diseases

Volumn 69, Issue 1, 2010, Pages 249-254

  Hou, Y ^a   Rabquer, B J ^a   Gerber, M L ^a   Del Galdo, F ^b   Jimenez, S A ^b   Haines III, G K ^c   Barr, W G ^d   Massa, M C ^e   Seibold, J R ^a   Koch, A E ^a,f  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c YALE UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; JUNCTIONAL ADHESION MOLECULE A;

ADULT; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL STRAIN U937; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKIN BIOPSY; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADULT; ARM; BLOOD VESSELS; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MYELOID CELLS; SCLERODERMA, DIFFUSE; SKIN; U937 CELLS;

EID: 73449090448     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.102624     Document Type: Article

References (21)

1. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
2. Kumar P, Hosaka S, Koch AE. Soluble E-selectin induces monocyte chemotaxis through Src family tyrosine kinases. J Biol Chem 2001;276:21039-45.
3. Sato S. Abnormalities of adhesion molecules and chemokines in scleroderma. Curr Opin Rheumatol 1999;11:503-7.
4. Abraham D, Lupoli S, McWhirter A, et al. Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum 1991;34:1164-72.
5. Koch AE, Kronfeld-Harrington LB, Szekanecz Z, et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993;61:239-46.
6. Liu Y, Nusrat A, Schnell FJ, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000;113:2363-74.
7. Ostermann G, Weber KS, Zernecke A, et al. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002;3:151-8.
8. Naik MU, Mousa SA, Parkos CA, et al. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 2003;102:2108-14.
9. Anonymous. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
10. Rabquer BJ, Pakozdi A, Michel JE, et al. Junctional adhesion molecule-C mediates leukocyte adhesion to the rheumatoid arthritis synovium. Arthritis Rheum In press.
11. Louneva N, Huaman G, Fertala J, et al. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum 2008;58:3020-9.
12. Fleming JN, Schwartz SM. The pathology of scleroderma vascular disease. Rheum Dis Clin North Am 2008;34:41-55; vi.
13. Corada M, Chimenti S, Cera MR, et al. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemiare-perfusion injury. Proc Natl Acad Sci USA 2005;102:10634-9.
14. Del Maschio A, De Luigi A, Martin-Padura I, et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 1999;190:1351-6.
15. Martin-Padura I, Lostaglio S, Schneemann M, et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998;142:117-27.
16. Woodfin A, Reichel CA, Khandoga A, et al. JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007;110:1848-56.
17. Cooke VG, Naik MU, Naik UP. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler Thromb Vasc Biol 2006;26:2005-11.
18. Cavusoglu E, Kornecki E, Sobocka MB, et al. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. J Am Coll Cardiol 2007;50:1768-76.
19. Rudnicka L, Majewski S, Blaszczyk M, et al. Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1992;35:771-5.
20. Naik MU, Naik UP. Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin alpha v beta 3 specific. J Cell Sci 2006;119:490-9.
21. Naik MU, Vuppalanchi D, Naik UP. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol 2003;23:2165-71.